E. Ohman J:or Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $78.3M | Buy |
65,270
+37,773
| +137% | +$38.6M | 1.82% | 9 |
|
|
2026
Q1 | $25.3M | Buy |
27,497
+171
| +0.6% | +$173K | 0.67% | 37 |
|
|
2025
Q4 | $29.4M | Sell |
27,326
-14,254
| -34% | -$13.6M | 0.68% | 36 |
|
|
2025
Q3 | $31.7M | Buy |
41,580
+1,547
| +4% | +$1.15M | 0.75% | 32 |
|
|
2025
Q2 | $31.2M | Sell |
40,033
-53,163
| -57% | -$41.3M | 0.77% | 33 |
|
|
2025
Q1 | $77M | Buy |
93,196
+2,942
| +3% | +$2.45M | 2.05% | 9 |
|
|
2024
Q4 | $69.7M | Buy |
90,254
+17,259
| +24% | +$14.3M | 1.62% | 12 |
|
|
2024
Q3 | $64.7M | Buy |
72,995
+6,915
| +10% | +$6.22M | 1.6% | 12 |
|
|
2024
Q2 | $59.8M | Buy |
66,080
+3,890
| +6% | +$3.11M | 1.48% | 11 |
|
|
2024
Q1 | $48.4M | Buy |
62,190
+22,790
| +58% | +$16.2M | 1.23% | 19 |
|
|
2023
Q4 | $23M | Buy |
39,400
+16,704
| +74% | +$9.75M | 0.84% | 36 |
|
|
2023
Q3 | $12.2M | Buy |
22,696
+8,600
| +61% | +$4.43M | 0.46% | 46 |
|
|
2023
Q2 | $6.61M | Sell |
14,096
-5,000
| -26% | -$2.1M | 0.24% | 62 |
|
|
2023
Q1 | $6.56M | Buy |
19,096
+3,000
| +19% | +$1.01M | 0.26% | 63 |
|
|
2022
Q4 | $5.89M | Hold |
16,096
| – | – | 0.26% | 64 |
|
|
2022
Q3 | $5.2M | Buy |
+16,096
| New | +$5.1M | 0.24% | 69 |
|
|
2022
Q1 | – | Sell |
-39,800
| Closed | -$11M | – | 443 |
|
|
2021
Q4 | $11M | Buy |
+39,800
| New | +$10.1M | 0.32% | 57 |
|
|
2021
Q3 | – | Sell |
-20,600
| Closed | -$4.73M | – | 470 |
|
|
2021
Q2 | $4.73M | Buy |
+20,600
| New | +$4.14M | 0.15% | 96 |
|
|
2019
Q4 | – | Sell |
-22,760
| Closed | -$2.55M | – | 455 |
|
|
2019
Q3 | $2.55M | Buy |
22,760
+1,200
| +6% | +$134K | 0.16% | 79 |
|
|
2019
Q2 | $2.39M | Sell |
21,560
-2,500
| -10% | -$294K | 0.16% | 79 |
|
|
2019
Q1 | $3.12M | Sell |
24,060
-193,427
| -89% | -$23.5M | 0.21% | 69 |
|
|
2018
Q4 | $25.2M | Sell |
217,487
-30,629
| -12% | -$3.42M | 1.83% | 12 |
|
|
2018
Q3 | $26.6M | Sell |
248,116
-22,921
| -8% | -$2.29M | 1.72% | 15 |
|
|
2018
Q2 | $23.1M | Buy |
271,037
+56,514
| +26% | +$4.64M | 1.65% | 15 |
|
|
2018
Q1 | $16.6M | Buy |
214,523
+8,868
| +4% | +$714K | 1.33% | 20 |
|
|
2017
Q4 | $17.4M | Buy |
205,655
+37,523
| +22% | +$3.19M | 1.41% | 16 |
|
|
2017
Q3 | $14.4M | Buy |
168,132
+141,932
| +542% | +$11.6M | 1.28% | 22 |
|
|
2017
Q2 | $2.16M | Hold |
26,200
| – | – | 0.22% | 78 |
|
|
2017
Q1 | $2.2M | Buy |
26,200
+3,900
| +17% | +$312K | 0.27% | 76 |
|
|
2016
Q4 | $1.64M | Buy |
22,300
+1,200
| +6% | +$89.4K | 0.23% | 88 |
|
|
2016
Q3 | $1.69M | Buy |
21,100
+1,500
| +8% | +$120K | 0.25% | 80 |
|
|
2016
Q2 | $1.54M | Buy |
19,600
+2,100
| +12% | +$158K | 0.26% | 76 |
|
|
2016
Q1 | $1.26M | Sell |
17,500
-1,600
| -8% | -$121K | 0.23% | 82 |
|
|
2015
Q4 | $1.61M | Hold |
19,100
| – | – | 0.28% | 75 |
|
|
2015
Q3 | $1.6M | Sell |
19,100
-1,900
| -9% | -$160K | 0.43% | 55 |
|
|
2015
Q2 | $1.75M | Sell |
21,000
-1,300
| -6% | -$99.1K | 0.41% | 56 |
|
|
2015
Q1 | $1.62M | Hold |
22,300
| – | – | 0.38% | 61 |
|
|
2014
Q4 | $1.55M | Hold |
22,300
| – | – | 0.37% | 62 |
|
|
2014
Q3 | $1.45M | Hold |
22,300
| – | – | 0.35% | 61 |
|
|
2014
Q2 | $1.39M | Hold |
22,300
| – | – | 0.34% | 68 |
|
|
2014
Q1 | $1.31M | Sell |
22,300
-3,200
| -13% | -$179K | 0.33% | 69 |
|
|
2013
Q4 | $1.3M | Sell |
25,500
-1,300
| -5% | -$65.1K | 0.31% | 72 |
|
|
2013
Q3 | $1.35M | Buy |
26,800
+2,500
| +10% | +$131K | 0.34% | 67 |
|
|
2013
Q2 | $1.19M | Buy |
+24,300
| New | +$1.32M | 0.33% | 66 |
|
Other funds holding LLY
SC
ONB
E. Ohman J:or Asset Management's LLY Position: Q2 2026 in Review
E. Ohman J:or Asset Management increased its Eli Lilly (LLY) stake by 137% in Q2 2026, buying an estimated $38.6M and bringing the position to 65,270 shares worth $78.3M. The position accounts for 1.82% of the portfolio, ranked #9.
E. Ohman J:or Asset Management first reported a position in LLY in Q2 2013 and has held it in 44 quarters since. 2,115 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- E. Ohman J:or Asset Management held 65,270 shares of Eli Lilly worth $78.3M as of Q2 2026.
- E. Ohman J:or Asset Management bought 37,773 Eli Lilly shares in Q2 2026, an estimated $38.6M.
- Eli Lilly made up 1.82% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #9 holding.
- E. Ohman J:or Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 44 quarters since.
- 2,115 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.